This inventor holds 2 USPTO granted patents. Top assignees: Les Laboratoires Servier, Vernalis (R&D) Ltd. Active years: 2026.
Company Filing History:
2 out of 295 
2 out of 4 Years Active: 2026
Title: Andràs Herner: Innovator in Cancer Treatment
Introduction
Andràs Herner is a notable inventor based in Tata, Hungary. He has made significant contributions to the field of cancer treatment through his innovative research and development efforts. His work focuses on the development of compounds that can inhibit specific proteins associated with cancer progression.
Latest Patents
Andràs Herner holds a patent for "6,7-Dihydro-5H-pyrido[2,3-c]pyridazine derivatives and related compounds as BCL-XL protein inhibitors and pro-apoptotic agents for treating cancer." This patent highlights his commitment to finding effective solutions for cancer therapy. He has 1 patent to his name, showcasing his innovative contributions to medical science.
Career Highlights
Throughout his career, Andràs has worked with prominent companies in the pharmaceutical industry. He has been associated with Les Laboratoires Servier and Vernalis (R&D) Ltd., where he contributed to research and development projects aimed at advancing cancer treatment options. His expertise in the field has made him a valuable asset to these organizations.
Collaborations
Andràs has collaborated with various professionals in his field, including his coworker Tibor Novák. These collaborations have further enhanced his research and development efforts, leading to innovative solutions in cancer treatment.
Conclusion
Andràs Herner is a dedicated inventor whose work in cancer treatment has the potential to make a significant impact on patient care. His innovative approach and commitment to research continue to drive advancements in the field.